Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ORCHPHARMA.NSthis companyOrchid Pharma Limited	₹884.00	119.12×	1.9×	3.02×	57.3×	-115.8%	19.5%	0.7%	2.5%	1.6%	0.3%	-11.2%	0.28×	7.27×	0.43×	2.45×	0.0%	4	—	1	C-
ANUHPHR.NSAnuh Pharma Limited	₹82.78	16.37×	1.91×	0.87×	10.04×	12.6%	17.4%	6.5%	5.3%	11.7%	10.8%	-1.6%	0×	-0.12×	106.58×	2.22×	2.2%	—	—	2	C
APLLTD.NSAlembic Pharmaceuticals Limited	₹1,017.30	19.32×	2.3×	1.77×	12.9×	3.1%	45.1%	10.9%	9.2%	11.9%	10.4%	2.0%	0.25×	1.11×	8.54×	1.76×	1.7%	4	—	2	B-
GLAND.NSGland Pharma Limited	₹3,302.40	27.2×	2.7×	4.35×	12.94×	-57.3%	30.0%	18.8%	16.0%	9.9%	7.6%	2.6%	0.03×	-1.6×	36.24×	4.68×	1.1%	5	—	2	C+
GRANULES.NSGranules India Limited	₹799.20	25.35×	2.97×	2.81×	13.13×	-42.2%	43.0%	16.6%	11.1%	11.7%	10.1%	0.8%	0.3×	0.52×	7.77×	1.8×	0.2%	5	—	2	C+
GUFICBIO.NSGufic Biosciences Limited	₹474.35	42.78×	4.13×	2.91×	19.97×	-117.2%	36.0%	12.8%	6.8%	9.7%	8.1%	-0.7%	0.61×	2.13×	3.29×	1.55×	0.0%	6	—	1	C-
Peer median	—	25.35×	2.7×	2.81×	12.94×	-42.2%	36.0%	12.8%	9.2%	11.7%	10.1%	0.8%	0.25×	0.52×	8.54×	1.8×	1.1%	5	—	2	—